In this context, UTX and mixed-lineage leukemia 4, which catalyzes H3K4 methylation, work synergistically to regulate gene transcription involved in breast cancer progression, correlating with poor clinical prognosis. The gene discussed is KDM6A; the disease is breast cancer.